Autoimmune disease biotech Odyssey sets terms for $225m IPO - pharmaphorum
Autoimmune disease biotech Odyssey sets terms for $225m IPO pharmaphorum
ORIGINAL SOURCE →via IPO News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] EU plans €6M program to support Palestinian victims of extremist settler violence
- [FINANCE] BREAKING: Jim Ovia retires as Zenith Bank chairman
- [FINANCE] Indonesia caps ride-hailing commission fees at 8% in ‘radical correction’ of sector
- [FINANCE] Australians are poorer because of war on the other side of the world – Michele Bullock’s logic is hard to fault
- [FINANCE] SIX to merge traditional and digital asset servicing into a single unit
- [FINANCE] Hyperscale Data reports bitcoin holdings valued at $53.5 million